<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Dev Reprod</journal-id><journal-id journal-id-type="iso-abbrev">Dev Reprod</journal-id><journal-id journal-id-type="publisher-id">Dev. Reprod.</journal-id><journal-id journal-id-type="publisher-id">dr</journal-id><journal-title-group><journal-title>Development &#x00026; Reproduction</journal-title></journal-title-group><issn pub-type="ppub">2465-9525</issn><issn pub-type="epub">2465-9541</issn><publisher><publisher-name>Korean Society of Developmental Biology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31660454</article-id><article-id pub-id-type="pmc">6812973</article-id><article-id pub-id-type="doi">10.12717/DR.2019.23.3.277</article-id><article-id pub-id-type="publisher-id">dr-23-3-277</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research Paper</subject></subj-group></article-categories><title-group><article-title>Proline-Rich Acidic Protein 1 (PRAP1) is a Target of ARID1A and PGR
in the Murine Uterus</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Tae Hoon</given-names></name><xref ref-type="aff" rid="AF1"/></contrib><contrib contrib-type="author"><name><surname>Jeong</surname><given-names>Jae-Wook</given-names></name><xref ref-type="aff" rid="AF1"/><xref ref-type="corresp" rid="C1"><sup>&#x02020;</sup></xref></contrib></contrib-group><aff id="AF1"><institution>Dept. of Obstetrics, Gynecology &#x00026; Reproductive
Biology, Michigan State University College of Human Medicine</institution>,
<addr-line>Grand Rapids, MI 49503, USA</addr-line></aff><author-notes><corresp id="C1"><label>&#x02020;</label>Corresponding Author : Jae-Wook Jeong,
Ph.D., Dept. of Obstetrics, Gynecology &#x00026; Reproductive Biology, Michigan
State University College of Human Medicine, Grand Rapids, MI 49503, USA. Tel:
<phone>+1-616-234-0987</phone>, Fax:
<fax>+1-616-234-2733</fax>, E-mail:
<email>jeongj@msu.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>9</month><year>2019</year></pub-date><pub-date pub-type="epub"><day>30</day><month>9</month><year>2019</year></pub-date><volume>23</volume><issue>3</issue><fpage>277</fpage><lpage>284</lpage><history><date date-type="received"><day>26</day><month>7</month><year>2019</year></date><date date-type="rev-recd"><day>13</day><month>8</month><year>2019</year></date><date date-type="accepted"><day>05</day><month>9</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; Copyright 2019 The Korean Society of Developmental
Biology</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License (<uri xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0</uri>) which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium, provided the original work is properly cited.</license-p></license></permissions><abstract abstract-type="executive-summary"><title>ABSTRACT</title><p>ARID1A and PGR plays an important role in embryo implantation and decidualization
during early pregnancy. Uterine specific <italic>Arid1a</italic> knockout
(<italic>Pgr<sup>cre/+</sup>Arid1a<sup>f/f</sup></italic>) mice
exhibit in non-receptive endometrium at day 3.5 of gestation (GD 3.5). In
previous studies, using transcriptomic analysis in the uterus of
<italic>Pgr<sup>cre/+</sup>Arid1a<sup>f/f</sup></italic> mice, we
identified proline-rich acidic protein 1 (<italic>PRAP1</italic>) as one of the
down-regulated genes by ARID1A in the uterus. In the present study, we performed
RT-qPCR and immunohistochemistry analysis to investigate the regulation of PRAP1
by ARID1A and determine expression patterns of PRAP1 in the uterus during early
pregnancy. During early pregnancy, PRAP1 expression was strong at day 0.5 of
gestation (GD 0.5) and then decreased at GD 3.5 in the epithelium and stroma.
After implantation, PRAP1 expression was remarkably reduced in the uterus.
However, the expression of PRAP1 at GD 3.5 was remarkably increased in the
<italic>Pgr<sup>cre/+</sup>Arid1a<sup> f/f</sup></italic> mice.
To determine the ovarian steroid hormone regulation of PRAP1, we examined the
expression of PRAP1 in ovariectomized control,
<italic>Pgr<sup>cre/+</sup>Arid1a<sup>f/f</sup></italic>, and
progesterone receptor knock-out (PRKO) mice treated with progesterone. While
PRAP1 proteins were strongly expressed in the luminal and glandular epithelium
of control mice treated with vehicle, progesterone treatment suppressed the
expression of PRAP1. However, PRAP1 was not suppressed in both the
<italic>Pgr<sup>cre/+</sup>Arid1a<sup>f/f</sup></italic> and PRKO
mice compared to controls. Our results identified PRAP1 as a novel target of
ARID1A and PGR in the murine uterus.</p></abstract><kwd-group kwd-group-type="key-words"><kwd>ARID1A</kwd><kwd>Uterus</kwd><kwd>Implantation</kwd><kwd>Progesterone</kwd><kwd>Estrogen</kwd><kwd>PRAP1</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>crossmark</meta-name><meta-value>2019-09-30</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="ss1"><title>INTRODUCTION</title><p>The primary function of the uterus is supporting fertility, and the endometrium is
the layer critically involved in receiving an embryo, facilitating implantation and
decidualization, and supporting embryo growth and development until placentation
(<xref rid="ref24" ref-type="bibr">Marquardt et al., 2019</xref>). The uterus is
a target tissue of ovarian steroid hormones. Estradiol (E2) stimulates endometrial
proliferation and growth, while progesterone (P4) suppresses E2 induced epithelial
cell proliferation, concomitant with initiation of stromal cell differentiation
(<xref rid="ref24" ref-type="bibr">Marquardt et al., 2019</xref>). These dynamic
changes are necessary for embryo implantation and successful pregnancy (<xref rid="ref29" ref-type="bibr">Tabibzadeh, 1998</xref>). The endometrium undergoes
well-defined and regulated gene expression in preparation for implantation (<xref rid="ref7" ref-type="bibr">Fox et al., 2016</xref>).</p><p>The physiological effects of P4 are mediated by the progesterone receptor (PGR). P4
and PGR together play a central role in reproductive events associated with the
establishment and maintenance of pregnancy. PGR regulates implantation,
decidualization, and glandular development via a complex paracrine signaling network
(<xref rid="ref33" ref-type="bibr">Wetendorf &#x00026; DeMayo, 2014</xref>; <xref rid="ref1" ref-type="bibr">Adams &#x00026; DeMayo, 2015</xref>; <xref rid="ref2" ref-type="bibr">Bhurke et al., 2016</xref>). The pivotal role of PGR
within reproductive tissues causes it to be an area of focus within reproductive
diseases (<xref rid="ref31" ref-type="bibr">Teasley et al., 2018</xref>).
Specifically, reduced expression of PGR has been associated with endometriosis, a
prevalent disease in women&#x02019;s health (<xref rid="ref9" ref-type="bibr">Grandi
et al., 2017</xref>). Overall, aberrations of steroid hormone signaling can be
found in many uterine disorders including infertility, endometriosis, endometrial
cancer, and uterine leiomyoma (<xref rid="ref13" ref-type="bibr">Han &#x00026;
O&#x02019;Malley, 2014</xref>; <xref rid="ref16" ref-type="bibr">Islam et al.,
2017</xref>; <xref rid="ref25" ref-type="bibr">Patel et al., 2017</xref>; <xref rid="ref36" ref-type="bibr">Yoo et al., 2017</xref>).</p><p>AT-rich interaction domain 1a (ARID1A) is one subunsit within the SWItch/Sucrose
Non-Fermentable (SWI/SNF) chromatin remodeling complex (<xref rid="ref3" ref-type="bibr">Chunder et al., 2003</xref>). It is located in chromosomal region
1p36, which is a region that is often deleted within many different forms of cancer
(<xref rid="ref3" ref-type="bibr">Chunder et al., 2003</xref>; <xref rid="ref30" ref-type="bibr">Takeda et al., 2016</xref>). A high frequency of
mutation of ARID1A in cancers, specifically endometrioid cancer of the uterus and
ovarian clear cell and endometrioid cancer, has revealed the potential of ARID1A to
be defined as a tumor suppressor (<xref rid="ref17" ref-type="bibr">Jones et al.,
2010</xref>; <xref rid="ref10" ref-type="bibr">Guan et al., 2011a</xref>).
ARID1A is able to inhibit tumor growth and cellular proliferation (<xref rid="ref11" ref-type="bibr">Guan et al., 2011b</xref>). Several studies have
linked SWI/SNF and ARID1A to transcriptional regulation, particularly nuclear
hormone-induced transcription and expression of cell cycle regulators (<xref rid="ref23" ref-type="bibr">Mao &#x00026; Shih, 2013</xref>; <xref rid="ref27" ref-type="bibr">Samartzis et al., 2013</xref>; <xref rid="ref34" ref-type="bibr">Wu &#x00026; Roberts, 2013</xref>). Previously, we have shown that
ARID1A protein levels are lower during both the proliferative and secretory phases,
in epithelial and stromal cells of women with endometriosis compared to those
without (<xref rid="ref19" ref-type="bibr">Kim et al., 2015</xref>). Ablation of
<italic>Arid1a</italic> in the murine uterus results in the inability to inhibit
E2-induced epithelial cell proliferation and E2-responsive target gene expression
(<xref rid="ref19" ref-type="bibr">Kim et al., 2015</xref>). However, the
molecular mechanism of ARID1A action in steroid hormone regulation and pregnancy is
not well studied.</p><p>Proline-rich acidic protein 1 (PRAP1) is a secretory protein of 149 amino acids, with
a 20 amino acid signal peptide at its N-terminal. PRAP1 has been identified as a
differentially expressed gene in the pregnant uterus of rodents (<xref rid="ref18" ref-type="bibr">Kasik &#x00026; Rice, 1997</xref>). It is strongly
expressed in the late pregnant uterus but disappears from the uterus within 3 days
after birth (<xref rid="ref18" ref-type="bibr">Kasik &#x00026; Rice, 1997</xref>).
Human <italic>PRAP1</italic> mRNA is detected in the gastrointestinal tract, liver,
and kidney. PRAP1 is localized in the epithelial lining of the colon and cervix, the
hepatocytes, and the kidney proximal and distal tubules (<xref rid="ref37" ref-type="bibr">Zhang et al., 2003</xref>). PRAP1 plays an important role in
maintaining normal growth homeostasis in epithelia (Lanemo <xref rid="ref20" ref-type="bibr">Myhrinder et al., 2008</xref>; <xref rid="ref37" ref-type="bibr">Zhang et al., 2003</xref>). PRAP1 is a p53-responsive gene induced by genotoxic
stress (<xref rid="ref14" ref-type="bibr">Huang et al., 2012</xref>). It is an
interacting partner of MAD1 and has a suppressive role in mitotic checkpoint
signaling in hepatocellular carcinoma (<xref rid="ref28" ref-type="bibr">Sze et al.,
2014</xref>). <italic>Prap1</italic> mRNA is highly expressed in the uterine
luminal epithelium of gestation day (GD) 0.5 in mice, disappears in the
preimplantation day 3.5 uterus, and reappears abundantly in the luminal epithelium
after embryo implantation (<xref rid="ref6" ref-type="bibr">Diao et al.,
2010</xref>). Therefore, PRAP1 is suggested as a marker for successful embryo
implantation (<xref rid="ref6" ref-type="bibr">Diao et al., 2010</xref>).</p><p>While <italic>Prap1</italic> is up-regulated by E2, it is down-regulated by P4 (<xref rid="ref6" ref-type="bibr">Diao et al., 2010</xref>; <xref rid="ref35" ref-type="bibr">Xiong et al., 2011</xref>). However, the regulation of PRAP1 in the
uterus is still elusive. In order to explore the regulation of PRAP1 expression in
the uterus, we investigated the expression of PRAP1 in the uterus of
<italic>Pgr</italic> knockout (PRKO) and uterine specific
<italic>Arid1a</italic> knockout
(<italic>Pgr<sup>cre/+</sup>Arid1a<sup>f/f</sup></italic>;
<italic>Arid1a<sup>d/d</sup></italic>) mice. We also evaluated the
regulation of PRAP1 in response to steroid hormones in the uterus.</p></sec><sec sec-type="materials|methods" id="ss2"><title>MATERIALS AND METHODS</title><sec id="ss3"><label>1.</label><title>Animals and tissue collection</title><p>All mouse experiments were approved by the Institutional Animal Care and Use
Committee of Michigan State University (IACUC number: 11/16-192-00). For the
uteri samples during early pregnancy, wild C57BL/6 female mice at 8 weeks of age
were individually mated with wild-type male mice and uteri were collected at
different time points of pregnancy. The initiation of pregnancy was marked by
the presence of the postcoital vaginal plug as day 0.5 of gestation (GD 0.5) for
early pregnancy study. In order to investigate the expression of PRAP1 by PGR
and ARID1A in the uterus, we used PRKO and <italic>Arid1a<sup>d/d</sup></italic>
mice (<xref rid="ref22" ref-type="bibr">Lydon et al., 1995</xref>; <xref rid="ref19" ref-type="bibr">Kim et al., 2015</xref>). We previously
generated mice with conditional ablation of <italic>Arid1a</italic> in the PGR
positive cells (<italic>Arid1a<sup>d/d</sup></italic>) to study the role of
<italic>Arid1a</italic> in the uterus (<xref rid="ref19" ref-type="bibr">Kim
et al., 2015</xref>). Uterine tissues were collected from both horns then
were stored at &#x02212;80&#x000b0;C for RNA or fixed in 4%
paraformaldehyde (vol/vol) and paraffin embedded.</p><p>To study PRAP1 expression by steroid hormone regulation, wild-type C57BL/6 mice,
<italic>Arid1a<sup>d/d</sup></italic> or PRKO mice at 6 weeks of age
underwent bilateral ovariectomy. After at least 2 weeks to eliminate endogenous
ovarian hormone completely, the mice were given subcutaneous injection with
vehicle (sesame oil) or P4 (1mg/mouse) (n=3 per genotype per treatment).
The uteri were collected at 6 hours after the steroid hormone injection.</p><p>To study PRAP1 expression by steroid hormone regulation, wild-type C57BL/6 mice,
<italic>Arid1a<sup>d/d</sup></italic> or PRKO mice at 6 weeks of age
underwent bilateral ovariectomy. After at least 2 weeks to eliminate endogenous
ovarian hormone completely, the mice were given subcutaneous injection with
vehicle (sesame oil) or P4 (1mg/mouse) (n=3 per genotype per treatment).
The uteri were collected at 6 hours after the steroid hormone injection.</p></sec><sec id="ss4"><label>2.</label><title>RNA isolation and quantitative real-time PCR</title><p>Total RNA was isolated from uteri using Qiagen RNeasy total RNA isolation kit
(Qiagen, Valencia, CA, USA). The expression levels of <italic>Prap1</italic>
were quantified by RT-qPCR using an Applied Biosystems StepOnePlus system
according to the manufacturer&#x02019;s instructions (Applied Biosystem, Foster
City, CA, USA). The cDNAs were synthesized with MMLV Reverse Transcriptase
(Invitrogen, Carlsbad, CA, USA) by the use of 1 &#x003bc;g of total RNA primed
with random hexamer primers according to the manufacturer&#x02019;s instructions.
RT-qPCR was performed on cDNA to assess the expression levels of genes of
interest with primers, by using SYBR green and 96-well optical plates, with an
Applied Biosystems StepOnePlus (Applied Biosystem, Foster City, CA, USA).
Experimental <italic>Prap1</italic> data were normalized to 18S ribosomal RNA.
Analysis of <italic>Prap1</italic> mRNA expression was first undertaken by the
standard curve method, and results were corroborated by CT values assessing
levels of gene expression. All data are presented as mean &#x000b1; SEM.
Statistical analyses were performed using Student&#x02019;s
<italic>t</italic>-tests using the Instat package from GraphPad (San Diego, CA,
USA). <italic>p</italic>&#x0003c;0.05 was considered statistically
significant.</p></sec><sec id="ss5"><label>3.</label><title>Immunohistochemistry</title><p>Uterine sections of 5&#x003bc;m thickness were blocked with 10% normal goat
serum in PBS (pH 7.5) for immunohistochemistry. Sections were exposed to primary
anti-PRAP1 (HPA038713, Sigma-Aldrich, St. Louis, MO, USA) antibody in 10%
normal goat serum in PBS (pH 7.5) overnight at 4&#x000b0;C. The Sections were
incubated with biotinylated goat anti-rabbit 2nd antibody (BA-1000; Vector
Laboratories, Burlingame, CA, USA). Following exposure to the horseradish
peroxidase-conjugated streptavidin substrate, positive immunoreactivity (brown
precipitate) was detected using the Vectastain Elite DAB kit (Vector
Laboratories, Burlingame, CA, USA) and hematoxylin (Biocare Medical, Pacheco,
CA, USA) were used for a nuclear counterstain.</p></sec></sec><sec sec-type="results" id="ss6"><title>RESULTS</title><sec id="ss7"><label>1.</label><title>PRAP1 is a target of ARID1A in the murine uterus</title><p>ARID1A has a critical role in modulating epithelial proliferation at the
pre-implantation stage which is a critical requisite for uterine receptivity
(<xref rid="ref19" ref-type="bibr">Kim et al., 2015</xref>). To determine
transcriptional regulation of <italic>Prap1</italic> by ARID1A, RT-qPCR was
performed in the uteri of control (<italic>Arid1a<sup>f/f</sup></italic>) and
<italic>Pgr<sup>cre/+</sup>Arid1a<sup>f/f</sup></italic>
(<italic>Arid1a<sup>d/d</sup></italic>) mice (<xref rid="ref19" ref-type="bibr">Kim et al., 2015</xref>) at GD 3.5. The results revealed that
there was a significant increase in <italic>Prap1</italic> mRNA expression in
the <italic>Arid1a<sup>d/d</sup></italic> mice uterus compared to the control
mice (<xref ref-type="fig" rid="f1">Fig. 1A</xref>). This result was extended
through immunohistochemistry to examine spatial expression of PRAP1 protein in
the <italic>Arid1a<sup>d/d</sup></italic> mice (<xref ref-type="fig" rid="f1">Fig. 1B</xref>). Control samples at GD 3.5 showed very weak PRAP1
expression within the uterine epithelial, glandular, and stromal cells. However,
<italic>Arid1a<sup>d/d</sup></italic> mice showed a remarkable increase
in PRAP1 expression throughout when compared to control mice. These data suggest
that the expression of PRAP1 is suppressed by ARID1A.</p><fig id="f1" orientation="portrait" position="float"><label>Fig. 1.</label><caption><title>The expression of PRAP1 in the uteri of control,
<italic>Arid1a<sup>d/d</sup></italic>, and PRKO mice. (A) The
expression pattern of <italic>Prap1</italic> from control and
<italic>Arid1a<sup>d/d</sup></italic> mice uteri determined by
RT-qPCR. Total RNA used for RT-qPCR assay was prepared from control and
<italic>Arid1a<sup>d/d</sup></italic> mice uteri at GD 3.5. The
results represent the mean &#x000b1; SEM of three independent RNA sets.
<italic>p</italic>&#x0003e;0.05. (B) The localization pattern of
PRAP1 proteins by immunohistochemistry in the uteri of control (a) and
<italic>Arid1a<sup>d/d</sup></italic> (b) mice. Uterine sections
were collected from control and <italic>Arid1a<sup>d/d</sup></italic>
mice at GD 3.5. PRAP1, proline-rich acidic protein 1; GD, day of
gestation.</title></caption><graphic xlink:href="dr-23-3-277-g1"/></fig></sec><sec id="ss8"><label>2.</label><title>The expression of PRAP1 in the uterus during early pregnancy</title><p>The expression of ARID1A mRNA and protein was strongly detected on GD 0.5, which
consistently expressed until GD 6.5 in the uterus (<xref rid="ref19" ref-type="bibr">Kim et al., 2015</xref>). To investigate the expression pattern
of PRAP1 in mouse uteri during early pregnancy, we performed
immunohistochemistry from GD 0.5 to GD 7.5 in the uteri of natural pregnancy
(<xref ref-type="fig" rid="f2">Fig. 2</xref>). The initiation of pregnancy
was marked by the presence of the postcoital vaginal plug (GD 0.5). At GD 0.5,
PRAP1 expression was present within uterine luminal and glandular epithelium,
however expression was not seen within stroma. At GD 2.5, expression increased,
and was also present within stroma. At GD 3.5 and 4.5, PRAP1 levels showed a
slight decrease in uterine epithelial and stromal cells. Interestingly, the
expression of PRAP1 was remarkably decreased after embryo implantation GD 5.5
and 7.5. The expression of PRAP1 was not observed in the uterus including the
primary and secondary decidual zone at GD 5.5 and 7.5. These data indicate that
PRAP1 is tightly regulated in the uterus during early pregnancy.</p><fig id="f2" orientation="portrait" position="float"><label>Fig. 2.</label><caption><title>The localization pattern of PRAP1 during early pregnancy.
Representative photomicrographs show immunohistochemical staining of
PRAP1 proteins in the uterus from GD 0.5 to GD 7.5. The arrow indicates
the embryo. PRAP1, proline-rich acidic protein 1; GD, day of
gestation.</title></caption><graphic xlink:href="dr-23-3-277-g2"/></fig></sec><sec id="ss9"><label>3.</label><title>The regulation of PRAP1 by P4 in the uterus</title><p>In order to evaluate PRAP1 expression in response to P4 treatment,
immunohistochemistry was performed on ovariectomized control (wild type and
<italic>Arid1a<sup>f/f</sup></italic>),
<italic>Arid1a<sup>d/d</sup></italic>, and PRKO mice treated with either
vehicle or P4 for 6 hours (<xref ref-type="fig" rid="f3">Fig. 3</xref>). PRAP1
expression was strongly detected at luminal and glandular epithelium of the
ovariectomized control mice treated with vehicle. After P4 treatment, the strong
PRAP1 expression disappeared at the luminal and glandular epithelium of control
mice. Both <italic>Arid1a<sup>d/d</sup></italic> and the PRKO mice showed
expression of PRAP1 after vehicle treatment. However, PRAP1 expression was not
changed in <italic>Arid1a<sup>d/d</sup></italic> and PRKO mice after P4
treatment. This data further reveals that PRAP1 is regulated by PGR and
ARID1A.</p><fig id="f3" orientation="portrait" position="float"><label>Fig. 3.</label><caption><title>The regulation of PRAP1 expression by ARID1A and PGR in the uterus.
Representative photomicrographs show the localization pattern of PRAP1
by immunohistochemistry in the vehicle or P4-treated uteri from control
(a and d), <italic>Arid1a<sup>d/d</sup></italic> (b and e), and PRKO (c
and f). Uterine sections were collected from ovariectomized control,
<italic>Arid1a<sup>d/d</sup></italic>, and PRKO that were
treated with vehicle (sesame oil; a-c) or P4 (d-f) for 6 hours. PRAP1,
proline-rich acidic protein 1; PRKO, progesterone receptor
knock-out.</title></caption><graphic xlink:href="dr-23-3-277-g3"/></fig></sec></sec><sec id="ss10"><title>DISCUSSION</title><p>Our study examined the regulation of <italic>Prap1</italic> by ARID1A and determined
the expression patterns of PRAP1 in the uterus during early pregnancy and in
response to ovarian steroid hormone treatment. In the present study, we report that
PRAP1 expression levels are remarkably increased in mice with conditional ablation
of <italic>Arid1a</italic> (<italic>Arid1a<sup>d/d</sup></italic>) (<xref ref-type="fig" rid="f1">Fig. 1</xref>). ARID1A plays a role as a transcriptional
repressor in breast cancer (<xref rid="ref12" ref-type="bibr">Guo et al.,
2018</xref>). Loss of ARID1A profoundly alters histone modifications and the
transcriptome. In response to a lack of <italic>Arid1a</italic>, mice did not
suppress the expression of PRAP1 by P4, further confirming ARID1A is a
transcriptional suppressor of <italic>Prap1</italic> gene.</p><p>Throughout implantation and early pregnancy, fluctuations in steroid hormone
expression are exhibited. GD 0.5 and 1.5 in murine pregnancy are the days in which
pre-ovulatory ovarian E2 is secreted, and proliferation occurs. From GD 2.5 on,
proliferation shifts from the luminal and glandular epithelial cells to the stromal
cells. Overall, we observed fluctuation of PRAP1 expression (<xref ref-type="fig" rid="f2">Fig. 2</xref>). At GD 2.5 expression levels were the highest overall.
E2 stimulated proliferation occurs during the first two days of pregnancy in the
mouse uterus (<xref rid="ref5" ref-type="bibr">Das, 2010</xref>). Our result is
consistent that PRAP1 is regulated by E2 (<xref rid="ref35" ref-type="bibr">Xiong et
al., 2011</xref>). At GD 4.5, implantation occurs, as stromal cells transition
into decidual cells in response to a blastocyst (Huet-<xref rid="ref15" ref-type="bibr">Hudson et al., 1989</xref>). We and others showed reduction of PRAP1
expression after implantation and down-regulation by P4 (<xref rid="ref6" ref-type="bibr">Diao et al., 2010</xref>; <xref rid="ref35" ref-type="bibr">Xiong et
al., 2011</xref>). The invading blastocyst then induces a decidualization
reaction of the P4-primed stromal cells, where they differentiate into
morphologically and functionally unique cells to surround the implanting embryo and
support growth until placentation, all under critical continued P4 regulation (<xref rid="ref24" ref-type="bibr">Marquardt et al., 2019</xref>). Therefore, PRAP1 is
a suppressed protein at the post-implantation stage.</p><p>PRKO is an invaluable model in assessing P4&#x02019;s role in gene and protein
expression. Past research has revealed that the ablation of PGR results in
abnormalities in the reproductive biology of the mouse and also a defect in the
implantation process (<xref rid="ref32" ref-type="bibr">Vasquez &#x00026; DeMayo,
2013</xref>). Within this study, we utilized the PRKO mouse model in order to
analyze the expression of PRAP1 in response to the ablation of both PGR isoforms
(<xref ref-type="fig" rid="f3">Fig. 3</xref>). Results showed a difference in
only epithelial expression of PRAP1 in the PRKO mouse model in comparison to
controls. Epithelial cells are associated with the production of paracrine factors,
mediated through the PGR receptors, which are critical in enhancing epithelial
differentiation and growth within the uterus (<xref rid="ref21" ref-type="bibr">Lee
et al., 2006</xref>; <xref rid="ref8" ref-type="bibr">Franco et al.,
2012</xref>). These results suggest that epithelial PRAP1 expression is regulated by
PGR.</p><p>P4 is a steroid hormone that is critical in reproductive processes, and has been
utilized for therapeutic treatment in peri-menopausal women who experience aberrant
bleeding or menstrual problems (<xref rid="ref26" ref-type="bibr">Prior,
2011</xref>; <xref rid="ref4" ref-type="bibr">Czyzyk et al., 2017</xref>). In order
to analyze P4&#x02019;s effect on PRAP1 expression, we examined PRAP1 expression
within control, <italic>Arid1a<sup>d/d</sup></italic>, and PRKO mice, with both
vehicle and 6-hour P4 treatment (<xref ref-type="fig" rid="f3">Fig. 3</xref>). In
this analysis we found that P4 treatment decreased expression in the control mice.
This result allows us to hypothesize P4&#x02019;s role in PRAP1 expression, and also
allows for a connection of P4 treatment in the two different mouse models. P4 does
not suppressed PRAP1 expression in the <italic>Arid1a<sup>d/d</sup></italic> mice.
PRAP1 plays normal epithelial cell homeostasis as a negative regulator and the
down-regulation of <italic>Prap1</italic> in cancer cells may lead to dysregulated
cell growth (<xref rid="ref37" ref-type="bibr">Zhang et al., 2003</xref>). Although
the regulation of PRAP1 expression by ovarian steroid hormone suggests a possible
connection to uterine function, molecular mechanisms of PRAP1 regulation should be
dissected in uterine function during early pregnancy.</p><p>Our results demonstrate that PRAP1 is a novel target of ARID1A and PGR in the murine
uterus. Additional research within this context would provide for greater insight
into the role of PRAP1 within the context of reproductive biology, and provide for a
new possible therapeutic target for uterine disorders.</p></sec></body><back><sec id="ss11" sec-type="COI-statement"><title>Conflict of interests</title><p>The authors declare no potential conflict of interest.</p></sec><ref-list><title>REFERENCES</title><ref id="ref1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>NR</given-names></name><name><surname>DeMayo</surname><given-names>FJ</given-names></name></person-group><year>2015</year><article-title>The role of steroid hormone receptors in the establishment of
pregnancy in rodents</article-title><source>Adv Anat Embryol Cell Biol</source><volume>216</volume><fpage>27</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-15856-3_3</pub-id><pub-id pub-id-type="pmid">26450493</pub-id></element-citation></ref><ref id="ref2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhurke</surname><given-names>AS</given-names></name><name><surname>Bagchi</surname><given-names>IC</given-names></name><name><surname>Bagchi</surname><given-names>MK</given-names></name></person-group><year>2016</year><article-title>Progesterone-regulated endometrial factors controlling
implantation</article-title><source>Am J Reprod Immunol</source><volume>75</volume><fpage>237</fpage><lpage>245</lpage><!--<pub-id pub-id-type="pmcid">PMC4754106</pub-id>--><pub-id pub-id-type="doi">10.1111/aji.12473</pub-id><pub-id pub-id-type="pmid">26804062</pub-id></element-citation></ref><ref id="ref3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chunder</surname><given-names>N</given-names></name><name><surname>Mandal</surname><given-names>S</given-names></name><name><surname>Basu</surname><given-names>D</given-names></name><name><surname>Roy</surname><given-names>A</given-names></name><name><surname>Roychoudhury</surname><given-names>S</given-names></name><name><surname>Panda</surname><given-names>CK</given-names></name></person-group><year>2003</year><article-title>Deletion mapping of chromosome 1 in early onset and late onset
breast tumors: A compa-rative study in eastern India</article-title><source>Pathol Res Pract</source><volume>199</volume><fpage>313</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1078/0344-0338-00423</pub-id><pub-id pub-id-type="pmid">12908521</pub-id></element-citation></ref><ref id="ref4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czyzyk</surname><given-names>A</given-names></name><name><surname>Podfigurna</surname><given-names>A</given-names></name><name><surname>Genazzani</surname><given-names>AR</given-names></name><name><surname>Meczekalski</surname><given-names>B</given-names></name></person-group><year>2017</year><article-title>The role of progesterone therapy in early preg-nancy: From
physiological role to therapeutic utility</article-title><source>Gynecol Endocrinol</source><volume>33</volume><fpage>421</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1080/09513590.2017.1291615</pub-id><pub-id pub-id-type="pmid">28277122</pub-id></element-citation></ref><ref id="ref5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>SK</given-names></name></person-group><year>2010</year><article-title>Regional development of uterine deciduali-zation: Molecular
signaling by Hoxa-10</article-title><source>Mol Reprod Dev</source><volume>77</volume><fpage>387</fpage><lpage>396</lpage><!--<pub-id pub-id-type="pmcid">PMC4267754</pub-id>--><pub-id pub-id-type="doi">10.1002/mrd.21133</pub-id><pub-id pub-id-type="pmid">19921737</pub-id></element-citation></ref><ref id="ref6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diao</surname><given-names>H</given-names></name><name><surname>Xiao</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name></person-group><year>2010</year><article-title>Uterine luminal epithelium-specific proline-rich acidic protein 1
(PRAP1) as a marker for successful embryo implantation</article-title><source>Fertil Steril</source><volume>94</volume><fpage>2808</fpage><lpage>2811</lpage><pub-id pub-id-type="doi">10.1016/j.fertnstert.2010.06.034</pub-id><pub-id pub-id-type="pmid">20674898</pub-id></element-citation></ref><ref id="ref7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>C</given-names></name><name><surname>Morin</surname><given-names>S</given-names></name><name><surname>Jeong</surname><given-names>JW</given-names></name><name><surname>Scott</surname><given-names>RT</given-names><suffix>Jr</suffix></name><name><surname>Lessey</surname><given-names>BA</given-names></name></person-group><year>2016</year><article-title>Local and systemic factors and implantation: What is the
evidence?</article-title><source>Fertil Steril</source><volume>105</volume><fpage>873</fpage><lpage>884</lpage><!--<pub-id pub-id-type="pmcid">PMC4821679</pub-id>--><pub-id pub-id-type="doi">10.1016/j.fertnstert.2016.02.018</pub-id><pub-id pub-id-type="pmid">26945096</pub-id></element-citation></ref><ref id="ref8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franco</surname><given-names>HL</given-names></name><name><surname>Rubel</surname><given-names>CA</given-names></name><name><surname>Large</surname><given-names>MJ</given-names></name><name><surname>Wetendorf</surname><given-names>M</given-names></name><name><surname>Fernandez-Valdivia</surname><given-names>R</given-names></name><name><surname>Jeong</surname><given-names>JW</given-names></name><name><surname>Spencer</surname><given-names>TE</given-names></name><name><surname>Behringer</surname><given-names>RR</given-names></name><name><surname>Lydon</surname><given-names>JP</given-names></name><name><surname>Demayo</surname><given-names>FJ</given-names></name></person-group><year>2012</year><article-title>Epithelial progesterone receptor exhibits pleiotropic roles in
uterine develop-ment and function</article-title><source>FASEB J</source><volume>26</volume><fpage>1218</fpage><lpage>1227</lpage><!--<pub-id pub-id-type="pmcid">PMC3289500</pub-id>--><pub-id pub-id-type="doi">10.1096/fj.11-193334</pub-id><pub-id pub-id-type="pmid">22155565</pub-id></element-citation></ref><ref id="ref9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grandi</surname><given-names>G</given-names></name><name><surname>Mueller</surname><given-names>MD</given-names></name><name><surname>Bersinger</surname><given-names>NA</given-names></name><name><surname>Facchinetti</surname><given-names>F</given-names></name><name><surname>McKinnon</surname><given-names>BD</given-names></name></person-group><year>2017</year><article-title>The association between proges-tins, nuclear receptors expression
and inflammation in endometrial stromal cells from women with
endome-triosis</article-title><source>Gynecol Endocrinol</source><volume>33</volume><fpage>712</fpage><lpage>715</lpage><pub-id pub-id-type="doi">10.1080/09513590.2017.1314458</pub-id><pub-id pub-id-type="pmid">28412861</pub-id></element-citation></ref><ref id="ref10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>B</given-names></name><name><surname>Mao</surname><given-names>TL</given-names></name><name><surname>Panuganti</surname><given-names>PK</given-names></name><name><surname>Kuhn</surname><given-names>E</given-names></name><name><surname>Kurman</surname><given-names>RJ</given-names></name><name><surname>Maeda</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>E</given-names></name><name><surname>Jeng</surname><given-names>YM</given-names></name><name><surname>Wang</surname><given-names>TL</given-names></name><name><surname>Shih</surname><given-names>IeM</given-names></name></person-group><year>2011a</year><article-title>Mutation and loss of expression of ARID1A in uterine low-grade
endometrioid carcinoma</article-title><source>Am J Surg Pathol</source><volume>35</volume><fpage>625</fpage><lpage>632</lpage><!--<pub-id pub-id-type="pmcid">PMC3077471</pub-id>--><pub-id pub-id-type="doi">10.1097/PAS.0b013e318212782a</pub-id><pub-id pub-id-type="pmid">21412130</pub-id></element-citation></ref><ref id="ref11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>TL</given-names></name><name><surname>Shih</surname><given-names>IeM</given-names></name></person-group><year>2011b</year><article-title>ARID1A, a factor that promotes formation of SWI/SNF-mediated
chro-matin remodeling, is a tumor suppressor in gyne-cologic
cancers</article-title><source>Cancer Res</source><volume>71</volume><fpage>6718</fpage><lpage>6727</lpage><!--<pub-id pub-id-type="pmcid">PMC3206175</pub-id>--><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-11-1562</pub-id><pub-id pub-id-type="pmid">21900401</pub-id></element-citation></ref><ref id="ref12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Mayakonda</surname><given-names>A</given-names></name><name><surname>Madan</surname><given-names>V</given-names></name><name><surname>Ding</surname><given-names>LW</given-names></name><name><surname>Lin</surname><given-names>LH</given-names></name><name><surname>Zia</surname><given-names>S</given-names></name><name><surname>Gery</surname><given-names>S</given-names></name><name><surname>Tyner</surname><given-names>JW</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Yin</surname><given-names>D</given-names></name><name><surname>Lin</surname><given-names>DC</given-names></name><name><surname>Koeffler</surname><given-names>HP</given-names></name></person-group><year>2018</year><article-title>ARID1A and CEBPalpha coopera-tively inhibit UCA1 transcription in
breast cancer</article-title><source>Oncogene</source><volume>37</volume><fpage>5939</fpage><lpage>5951</lpage><pub-id pub-id-type="doi">10.1038/s41388-018-0371-4</pub-id><pub-id pub-id-type="pmid">29980791</pub-id></element-citation></ref><ref id="ref13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>SJ</given-names></name><name><surname>O&#x02019;Malley</surname><given-names>BW</given-names></name></person-group><year>2014</year><article-title>The dynamics of nuclear receptors and nuclear receptor
coregulators in the pathogenesis of endometriosis</article-title><source>Human Reprod Update</source><volume>20</volume><fpage>467</fpage><lpage>484</lpage><!--<pub-id pub-id-type="pmcid">PMC4063700</pub-id>--><pub-id pub-id-type="doi">10.1093/humupd/dmu002</pub-id><pub-id pub-id-type="pmid">24634322</pub-id></element-citation></ref><ref id="ref14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>BH</given-names></name><name><surname>Zhuo</surname><given-names>JL</given-names></name><name><surname>Leung</surname><given-names>CH</given-names></name><name><surname>Lu</surname><given-names>GD</given-names></name><name><surname>Liu</surname><given-names>JJ</given-names></name><name><surname>Yap</surname><given-names>CT</given-names></name><name><surname>Hooi</surname><given-names>SC</given-names></name></person-group><year>2012</year><article-title>PRAP1 is a novel executor of p53-dependent mechanisms in cell
survival after DNA damage</article-title><source>Cell Death Dis</source><volume>3</volume><fpage>e442</fpage><!--<pub-id pub-id-type="pmcid">PMC3542616</pub-id>--><pub-id pub-id-type="doi">10.1038/cddis.2012.180</pub-id><pub-id pub-id-type="pmid">23235459</pub-id></element-citation></ref><ref id="ref15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huet-Hudson</surname><given-names>YM</given-names></name><name><surname>Andrews</surname><given-names>GK</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group><year>1989</year><article-title>Cell type-specific localization of c-myc protein in the mouse
uterus: Modulation by steroid hormones and analysis of the periimplantation
period</article-title><source>Endocrinology</source><volume>125</volume><fpage>1683</fpage><lpage>1690</lpage><pub-id pub-id-type="doi">10.1210/endo-125-3-1683</pub-id><pub-id pub-id-type="pmid">2667965</pub-id></element-citation></ref><ref id="ref16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>MS</given-names></name><name><surname>Ciavattini</surname><given-names>A</given-names></name><name><surname>Petraglia</surname><given-names>F</given-names></name><name><surname>Castellucci</surname><given-names>M</given-names></name><name><surname>Ciarmela</surname><given-names>P</given-names></name></person-group><year>2017</year><article-title>Extracellular matrix in uterine leiomyoma pathogenesis: A
potential target for future therapeutics</article-title><source>Human Reprod Update</source><volume>24</volume><fpage>59</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1093/humupd/dmx032</pub-id><pub-id pub-id-type="pmid">29186429</pub-id></element-citation></ref><ref id="ref17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>TL</given-names></name><name><surname>Shih</surname><given-names>IeM</given-names></name><name><surname>Mao</surname><given-names>TL</given-names></name><name><surname>Nakayama</surname><given-names>K</given-names></name><name><surname>Roden</surname><given-names>R</given-names></name><name><surname>Glas</surname><given-names>R</given-names></name><name><surname>Slamon</surname><given-names>D</given-names></name><name><surname>Diaz</surname><given-names>LA</given-names><suffix>Jr</suffix></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name><name><surname>Velculescu</surname><given-names>VE</given-names></name><name><surname>Papadopoulos</surname><given-names>N</given-names></name></person-group><year>2010</year><article-title>Frequent mutations of chromatin remodeling gene ARID1A in ovarian
clear cell carcinoma</article-title><source>Science</source><volume>330</volume><fpage>228</fpage><lpage>231</lpage><!--<pub-id pub-id-type="pmcid">PMC3076894</pub-id>--><pub-id pub-id-type="doi">10.1126/science.1196333</pub-id><pub-id pub-id-type="pmid">20826764</pub-id></element-citation></ref><ref id="ref18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasik</surname><given-names>J</given-names></name><name><surname>Rice</surname><given-names>E</given-names></name></person-group><year>1997</year><article-title>A novel complementary deoxyri-bonucleic acid is abundantly and
specifically expressed in the uterus during pregnancy</article-title><source>Am J Obstet Gynecol</source><volume>176</volume><fpage>452</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1016/S0002-9378(97)70514-3</pub-id><pub-id pub-id-type="pmid">9065197</pub-id></element-citation></ref><ref id="ref19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>TH</given-names></name><name><surname>Yoo</surname><given-names>JY</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Lydon</surname><given-names>JP</given-names></name><name><surname>Khatri</surname><given-names>S</given-names></name><name><surname>Hawkins</surname><given-names>SM</given-names></name><name><surname>Leach</surname><given-names>RE</given-names></name><name><surname>Fazleabas</surname><given-names>AT</given-names></name><name><surname>Young</surname><given-names>SL</given-names></name><name><surname>Lessey</surname><given-names>BA</given-names></name><name><surname>Ku</surname><given-names>BJ</given-names></name><name><surname>Jeong</surname><given-names>JW</given-names></name></person-group><year>2015</year><article-title>ARID1A is essential for endometrial function during early
pregnancy</article-title><source>PLOS Genet</source><volume>11</volume><lpage>e1005537</lpage><!--<pub-id pub-id-type="pmcid">PMC4574948</pub-id>--><pub-id pub-id-type="doi">10.1371/journal.pgen.1005537</pub-id><pub-id pub-id-type="pmid">26378916</pub-id></element-citation></ref><ref id="ref20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanemo Myhrinder</surname><given-names>A</given-names></name><name><surname>Hellqvist</surname><given-names>E</given-names></name><name><surname>Sidorova</surname><given-names>E</given-names></name><name><surname>Soderberg</surname><given-names>A</given-names></name><name><surname>Baxendale</surname><given-names>H</given-names></name><name><surname>Dahle</surname><given-names>C</given-names></name><name><surname>Willander</surname><given-names>K</given-names></name><name><surname>Tobin</surname><given-names>G</given-names></name><name><surname>Backman</surname><given-names>E</given-names></name><name><surname>Soderberg</surname><given-names>O</given-names></name><name><surname>Rosenquist</surname><given-names>R</given-names></name><name><surname>Horkko</surname><given-names>S</given-names></name><name><surname>Rosen</surname><given-names>A</given-names></name></person-group><year>2008</year><article-title>A new perspective: Molecular motifs on oxidized LDL, apoptotic
cells, and bacteria are targets for chronic lymphocytic leukemia
antibodies</article-title><source>Blood</source><volume>111</volume><fpage>3838</fpage><lpage>3848</lpage><pub-id pub-id-type="doi">10.1182/blood-2007-11-125450</pub-id><pub-id pub-id-type="pmid">18223168</pub-id></element-citation></ref><ref id="ref21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Jeong</surname><given-names>J</given-names></name><name><surname>Tsai</surname><given-names>MJ</given-names></name><name><surname>Tsai</surname><given-names>S</given-names></name><name><surname>Lydon</surname><given-names>JP</given-names></name><name><surname>DeMayo</surname><given-names>FJ</given-names></name></person-group><year>2006</year><article-title>Molecular mechanisms involved in progeste-rone receptor
regulation of uterine function</article-title><source>J Steroid Biochem Mol Biol</source><volume>102</volume><fpage>41</fpage><lpage>50</lpage><!--<pub-id pub-id-type="pmcid">PMC2562605</pub-id>--><pub-id pub-id-type="doi">10.1016/j.jsbmb.2006.09.006</pub-id><pub-id pub-id-type="pmid">17067792</pub-id></element-citation></ref><ref id="ref22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lydon</surname><given-names>JP</given-names></name><name><surname>DeMayo</surname><given-names>FJ</given-names></name><name><surname>Funk</surname><given-names>CR</given-names></name><name><surname>Mani</surname><given-names>SK</given-names></name><name><surname>Hughes</surname><given-names>AR</given-names></name><name><surname>Montgomery</surname><given-names>CA</given-names><suffix>Jr</suffix></name><name><surname>Shyamala</surname><given-names>G</given-names></name><name><surname>Conneely</surname><given-names>OM</given-names></name><name><surname>O&#x02019;Malley</surname><given-names>BW</given-names></name></person-group><year>1995</year><article-title>Mice lacking progesterone recep-tor exhibit pleiotropic
reproductive abnormalities</article-title><source>Genes Dev</source><volume>9</volume><fpage>2266</fpage><lpage>2278</lpage><pub-id pub-id-type="doi">10.1101/gad.9.18.2266</pub-id><pub-id pub-id-type="pmid">7557380</pub-id></element-citation></ref><ref id="ref23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>TL</given-names></name><name><surname>Shih</surname><given-names>IeM</given-names></name></person-group><year>2013</year><article-title>The roles of ARID1A in gynecologic cancer</article-title><source>J Gynecol Oncol</source><volume>24</volume><fpage>376</fpage><lpage>381</lpage><!--<pub-id pub-id-type="pmcid">PMC3805919</pub-id>--><pub-id pub-id-type="doi">10.3802/jgo.2013.24.4.376</pub-id><pub-id pub-id-type="pmid">24167674</pub-id></element-citation></ref><ref id="ref24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marquardt</surname><given-names>RM</given-names></name><name><surname>Kim</surname><given-names>TH</given-names></name><name><surname>Shin</surname><given-names>JH</given-names></name><name><surname>Jeong</surname><given-names>JW</given-names></name></person-group><year>2019</year><article-title>Progesterone and estrogen signaling in the endometrium: What goes
wrong in endometriosis?</article-title><source>Int J Mol Sci</source><volume>20</volume><fpage>3822</fpage><!--<pub-id pub-id-type="pmcid">PMC6695957</pub-id>--><pub-id pub-id-type="doi">10.3390/ijms20153822</pub-id><pub-id pub-id-type="pmid">31387263</pub-id></element-citation></ref><ref id="ref25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>BG</given-names></name><name><surname>Rudnicki</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Shu</surname><given-names>Y</given-names></name><name><surname>Taylor</surname><given-names>RN</given-names></name></person-group><year>2017</year><article-title>Progesterone resistance in endometriosis: Origins, con-sequences
and interventions</article-title><source>Acta Obstet Gynecol Scand</source><volume>96</volume><fpage>623</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1111/aogs.13156</pub-id><pub-id pub-id-type="pmid">28423456</pub-id></element-citation></ref><ref id="ref26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prior</surname><given-names>JC</given-names></name></person-group><year>2011</year><article-title>Progesterone for symptomatic perimeno-pause treatment:
Progesterone politics, physiology and potential for
perimenopause</article-title><source>Facts Views Vis Obgyn</source><volume>3</volume><fpage>109</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">24753856</pub-id></element-citation></ref><ref id="ref27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samartzis</surname><given-names>EP</given-names></name><name><surname>Noske</surname><given-names>A</given-names></name><name><surname>Dedes</surname><given-names>KJ</given-names></name><name><surname>Fink</surname><given-names>D</given-names></name><name><surname>Imesch</surname><given-names>P</given-names></name></person-group><year>2013</year><article-title>ARID1A mutations and PI3K/AKT pathway alterations in
endometriosis and endometriosis-associated ovarian
carcinomas</article-title><source>Int J Mol Sci</source><volume>14</volume><fpage>18824</fpage><lpage>18849</lpage><!--<pub-id pub-id-type="pmcid">PMC3794809</pub-id>--><pub-id pub-id-type="doi">10.3390/ijms140918824</pub-id><pub-id pub-id-type="pmid">24036443</pub-id></element-citation></ref><ref id="ref28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sze</surname><given-names>KM</given-names></name><name><surname>Chu</surname><given-names>GK</given-names></name><name><surname>Mak</surname><given-names>QH</given-names></name><name><surname>Lee</surname><given-names>JM</given-names></name><name><surname>Ng</surname><given-names>IO</given-names></name></person-group><year>2014</year><article-title>Proline-rich acidic protein 1 (PRAP1) is a novel inte-racting
partner of MAD1 and has a suppressive role in mitotic checkpoint signalling
in hepatocellular carci-noma</article-title><source>J Pathol</source><volume>233</volume><fpage>51</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1002/path.4319</pub-id><pub-id pub-id-type="pmid">24374861</pub-id></element-citation></ref><ref id="ref29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabibzadeh</surname><given-names>S</given-names></name></person-group><year>1998</year><article-title>Molecular control of the implantation window</article-title><source>Hum Reprod Update</source><volume>4</volume><fpage>465</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1093/humupd/4.5.465</pub-id><pub-id pub-id-type="pmid">10027597</pub-id></element-citation></ref><ref id="ref30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname><given-names>T</given-names></name><name><surname>Banno</surname><given-names>K</given-names></name><name><surname>Okawa</surname><given-names>R</given-names></name><name><surname>Yanokura</surname><given-names>M</given-names></name><name><surname>Iijima</surname><given-names>M</given-names></name><name><surname>Irie-Kunitomi</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Iida</surname><given-names>M</given-names></name><name><surname>Adachi</surname><given-names>M</given-names></name><name><surname>Umene</surname><given-names>K</given-names></name><name><surname>Nogami</surname><given-names>Y</given-names></name><name><surname>Masuda</surname><given-names>K</given-names></name><name><surname>Kobayashi</surname><given-names>Y</given-names></name><name><surname>Tominaga</surname><given-names>E</given-names></name><name><surname>Aoki</surname><given-names>D</given-names></name></person-group><year>2016</year><article-title>ARID1A gene mutation in ovarian and endometrial cancers
(Review)</article-title><source>Oncol Rep</source><volume>35</volume><fpage>607</fpage><lpage>613</lpage><!--<pub-id pub-id-type="pmcid">PMC4689482</pub-id>--><pub-id pub-id-type="doi">10.3892/or.2015.4421</pub-id><pub-id pub-id-type="pmid">26572704</pub-id></element-citation></ref><ref id="ref31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teasley</surname><given-names>HE</given-names></name><name><surname>Chang</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>TH</given-names></name><name><surname>Ku</surname><given-names>BJ</given-names></name><name><surname>Jeong</surname><given-names>JW</given-names></name></person-group><year>2018</year><article-title>Expression of PIK3IP1 in the murine uterus during early
pregnancy</article-title><source>Biochem Biophys Res Commun</source><volume>495</volume><fpage>2553</fpage><lpage>2558</lpage><!--<pub-id pub-id-type="pmcid">PMC5762254</pub-id>--><pub-id pub-id-type="doi">10.1016/j.bbrc.2017.12.154</pub-id><pub-id pub-id-type="pmid">29289536</pub-id></element-citation></ref><ref id="ref32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasquez</surname><given-names>YM</given-names></name><name><surname>DeMayo</surname><given-names>FJ</given-names></name></person-group><year>2013</year><article-title>Role of nuclear receptors in blastocyst
implantation</article-title><source>Semin Cell Dev Biol</source><volume>24</volume><fpage>724</fpage><lpage>735</lpage><!--<pub-id pub-id-type="pmcid">PMC3849351</pub-id>--><pub-id pub-id-type="doi">10.1016/j.semcdb.2013.08.004</pub-id><pub-id pub-id-type="pmid">23994285</pub-id></element-citation></ref><ref id="ref33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wetendorf</surname><given-names>M</given-names></name><name><surname>DeMayo</surname><given-names>FJ</given-names></name></person-group><year>2014</year><article-title>Progesterone receptor signaling in the initiation of pregnancy
and preserva-tion of a healthy uterus</article-title><source>Int J Dev Biol</source><volume>58</volume><fpage>95</fpage><lpage>106</lpage><!--<pub-id pub-id-type="pmcid">PMC4413906</pub-id>--><pub-id pub-id-type="doi">10.1387/ijdb.140069mw</pub-id><pub-id pub-id-type="pmid">25023675</pub-id></element-citation></ref><ref id="ref34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>JN</given-names></name><name><surname>Roberts</surname><given-names>CW</given-names></name></person-group><year>2013</year><article-title>ARID1A mutations in cancer: Another epigenetic tumor
suppressor?</article-title><source>Cancer Discov</source><volume>3</volume><fpage>35</fpage><lpage>43</lpage><!--<pub-id pub-id-type="pmcid">PMC3546152</pub-id>--><pub-id pub-id-type="doi">10.1158/2159-8290.CD-12-0361</pub-id><pub-id pub-id-type="pmid">23208470</pub-id></element-citation></ref><ref id="ref35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>GF</given-names></name><name><surname>Zhang</surname><given-names>YS</given-names></name><name><surname>Han</surname><given-names>BC</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Peng</surname><given-names>JP</given-names></name></person-group><year>2011</year><article-title>Estradiol-regulated proline-rich acid protein 1 is repressed by
class I histone deacetylase and functions in peri-implantation mouse
uterus</article-title><source>Mol Cell Endocrinol</source><volume>331</volume><fpage>23</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2010.06.003</pub-id><pub-id pub-id-type="pmid">20547205</pub-id></element-citation></ref><ref id="ref36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>JY</given-names></name><name><surname>Yang</surname><given-names>WS</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>BG</given-names></name><name><surname>Broaddus</surname><given-names>RR</given-names></name><name><surname>Lim</surname><given-names>JM</given-names></name><name><surname>Kim</surname><given-names>TH</given-names></name><name><surname>Jeong</surname><given-names>JW</given-names></name></person-group><year>2017</year><article-title>MIG-6 negatively regulates STAT3 phosphorylation in uterine
epithelial cells</article-title><source>Oncogene</source><volume>37</volume><fpage>255</fpage><lpage>262</lpage><!--<pub-id pub-id-type="pmcid">PMC5764811</pub-id>--><pub-id pub-id-type="doi">10.1038/onc.2017.335</pub-id><pub-id pub-id-type="pmid">28925396</pub-id></element-citation></ref><ref id="ref37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Wong</surname><given-names>H</given-names></name><name><surname>Ramanan</surname><given-names>S</given-names></name><name><surname>Cheong</surname><given-names>D</given-names></name><name><surname>Leong</surname><given-names>A</given-names></name><name><surname>Hooi</surname><given-names>SC</given-names></name></person-group><year>2003</year><article-title>The proline-rich acidic protein is epigeneti-cally regulated and
inhibits growth of cancer cell lines</article-title><source>Cancer Res</source><volume>63</volume><fpage>6658</fpage><lpage>6665</lpage><pub-id pub-id-type="pmid">14583459</pub-id></element-citation></ref></ref-list></back></article>